Fundz

Sinopia Biosciences, Inc. secured a Phase II SBIR grant totaling $2.2M from the National Institute of Dental and Craniofacial Research to advance its oral mucositis program.

PRIVATESep 12, 2024

Amount Raised

$2.2 Million

Round Type

Seed

San DiegoBiotechnologyTherapeutics

Description

Sinopia Biosciences, Inc. has been awarded a Phase II SBIR grant of $2.2M from the NIDCR to support the discovery of novel treatments for oral mucositis. This grant will help in the development and optimization of small molecules to address this debilitating side effect of chemotherapy.

Quick answer

Sinopia Biosciences raised $2.2 Million in a Seed round, dated September 12, 2024. Sinopia Biosciences is based in San Diego, California, United States.

How much did Sinopia Biosciences raise?
Sinopia Biosciences raised $2.2 Million in a Seed round on September 12, 2024.
What does Sinopia Biosciences do?
Sinopia Biosciences, Inc. is a biotechnology company advancing novel therapeutics identified using its proprietary computational drug discovery platform.
Where is Sinopia Biosciences based and how big is it?
Sinopia Biosciences is based in San Diego, California, United States. Fundz records about 6 employees.
Who are the decision-makers at Sinopia Biosciences?
Fundz holds 1 contact at Sinopia Biosciences. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Sinopia Biosciences that raised within 45 days of this round, from Fundz verified event records.

  • Pathos AI raised $62M on October 24, 2024.
  • Ensho Therapeutics raised $5M on October 24, 2024.
  • Passkey Therapeutics raised $20M (Seed) on October 22, 2024.
  • AvenCell Therapeutics raised $112M (Series B) on October 22, 2024.
  • Seaport Therapeutics raised $225M (Series B) on October 21, 2024.
  • Seaport Therapeutics raised $226M on October 18, 2024.

Who to call at Sinopia Biosciences, and when

A new round usually means Sinopia Biosciences is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Sinopia Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Sinopia Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Sinopia Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Sinopia Biosciences

Location

San Diego, California, United States

About

Sinopia Biosciences, Inc. is a biotechnology company advancing novel therapeutics identified using its proprietary computational drug discovery platform.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Sinopia Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Sinopia Biosciences's next move

See what Strategic adds

Sinopia Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.